Literature DB >> 22491272

Tensha therapeutics.

Jennifer Rohn.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22491272     DOI： 10.1038/nbt0412-305

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Selective inhibition of BET bromodomains.

Authors:  Panagis Filippakopoulos; Jun Qi; Sarah Picaud; Yao Shen; William B Smith; Oleg Fedorov; Elizabeth M Morse; Tracey Keates; Tyler T Hickman; Ildiko Felletar; Martin Philpott; Shonagh Munro; Michael R McKeown; Yuchuan Wang; Amanda L Christie; Nathan West; Michael J Cameron; Brian Schwartz; Tom D Heightman; Nicholas La Thangue; Christopher A French; Olaf Wiest; Andrew L Kung; Stefan Knapp; James E Bradner
Journal:  Nature       Date:  2010-09-24       Impact factor: 49.962
  1 in total
  4 in total

Review 1.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

2.  Roche bets on bromodomains.

Authors:  Eva von Schaper
Journal:  Nat Biotechnol       Date:  2016-04       Impact factor: 54.908

3.  BET bromodomains regulate transforming growth factor-β-induced proliferation and cytokine release in asthmatic airway smooth muscle.

Authors:  Mark M Perry; Andrew L Durham; Philip J Austin; Ian M Adcock; Kian Fan Chung
Journal:  J Biol Chem       Date:  2015-02-19       Impact factor: 5.157

Review 4.  Seeding collaborations to advance kinase science with the GSK Published Kinase Inhibitor Set (PKIS).

Authors:  David H Drewry; Timothy M Willson; William J Zuercher
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.